Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Foresite Capital, founded in 2011, is a multi-stage venture capital firm based in Los Angeles, with additional offices in San Francisco and New York City. The firm manages approximately $3.5 billion in assets across six funds and has a portfolio of 206 companies. Jim Tananbaum, a Midas List honoree, leads the firm, which employs a data science-driven investment approach.
Foresite Capital invests between $50 million and $120 million in both early-stage and late-stage healthcare and life sciences companies. Their investment sectors include biotech, drug discovery, diagnostics, digital health, and genomics, with a particular emphasis on therapeutics in oncology, autoimmune diseases, and neuroscience. Foresite Labs incubates early concepts, providing support from inception to IPO.
Notable companies in Foresite Capital's portfolio include 10x Genomics, Relay Therapeutics, Editas Medicine, Juno Therapeutics, Vaxcyte, and Natera. The firm has achieved 237 exits, including 80 IPOs and 65 acquisitions.
Jim Tananbaum is the founder and CEO, recognized on the Midas List for his contributions to healthcare investing. His background includes founding several successful healthcare companies and a strong focus on life sciences investments.
Submit your pitch through their contact form at https://www.foresitecapital.com/contact/.
As of February 2026, Foresite Capital made its latest investment, continuing its active engagement in the healthcare sector.
Foresite Capital employs a data-driven approach, investing equally in early-stage and late-stage healthcare ventures. They focus on companies that leverage biology and big data to transform healthcare.
Foresite Labs incubates early concepts, providing resources and expertise to help startups develop their ideas from inception through to market readiness.
The firm targets companies in biotech, healthcare, drug discovery, diagnostics, and digital health, particularly those involved in therapeutics for oncology, autoimmune diseases, and neuroscience.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.